1-4 of 4
Authors: Stefan Sweha
Sort by
Journal Article
MDB-78. ISOCITRATE DEHYDROGENASE 1 INHIBITION PRIMES GROUP-3 MEDULLOBLASTOMAS FOR CUPROPTOSIS Open Access
Derek Dang and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.526
Published: 18 June 2024
Journal Article
TMET-02. CLINICAL EFFICACY OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IS DRIVEN BY DISRUPTION OF INTEGRATED METABOLIC AND EPIGENETIC PATHWAYS Free
Sriram Venneti and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v272, https://doi.org/10.1093/neuonc/noad179.1046
Published: 10 November 2023
Journal Article
CSIG-09. THERAPEUTIC TARGETING OF PRENATAL PONTINE ID1 SIGNALING IN DIFFUSE MIDLINE GLIOMA Free
Dana Messinger and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii40, https://doi.org/10.1093/neuonc/noac209.158
Published: 14 November 2022
Journal Article
TAMI-42. H3K27M MUTANT GLIOMAS HIJACK A CONSERVED AND CRITICAL METABOLIC PATHWAY USED BY IDH1 MUTANT GLIOMAS TO MAINTAIN THEIR PREFERRED EPIGENETIC STATE Free
Chan Chung and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii222, https://doi.org/10.1093/neuonc/noaa215.930
Published: 09 November 2020
Advertisement
Advertisement